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Personality Disorders (PDs) are particularly hard to treat and treatment drop-out rates
are high. Several authors have agreed that psychotherapy is more successful when it
focuses on the core of personality pathology. For this reason, therapists dealing with PDs
need to understand the psychopathological variables that characterize this pathology
and exactly what contributes to maintaining psychopathological processes. Moreover,
several authors have noted that one key problem that characterizes all PDs is an
impairment in understanding mental states – here termed metacognition – which could
also be responsible for therapy failures. Unfortunately, a limited number of studies have
investigated the role of mentalization in the process of change during psychotherapy.
In this paper, we assume that poor metacognition corresponds to a core element of
the general pathology of personality, impacts a series of clinical variables, generates
symptoms and interpersonal problems, and causes treatment to be slower and less
effective. We explored whether changes in metacognition predicted an improvement
among different psychopathological variables characterizing PDs; 193 outpatients were
treated at the Third Center of Cognitive Psychotherapy in Rome, Italy, and followed a
structured path tailored for the different psychopathological variables that emerged from
a comprehensive psychodiagnostic assessment that considered patients’ symptoms,
metacognitive abilities, interpersonal relationships, personality psychopathology, and
global functioning. The measurements were repeated after a year of treatment. The
results showed that changes in metacognitive abilities predicted improvements in the
analyzed variables.
Keywords: metacognition, mentalization, personality disorders, psychotherapeutic process, psychotherapy
outcome
INTRODUCTION
Psychotherapists and psychiatrists agree that Personality Disorders (PDs) are particularly
troublesome to treat. Although psychotherapy is considered to be the treatment of choice for all
PDs (Verheul and Herbrink, 2007; Livesley, 2012; Bamelis et al., 2014), the rate of treatment being
prematurely interrupted is high (McMurran et al., 2010; Barnicot et al., 2011; Swift and Greenberg,
2012; Gamache et al., 2018; Gülüm, 2018). Unfortunately, research largely focuses on the treatment
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of borderline personality disorder (BPD), which may be an
unjustified bias, since individuals with BPD represent a minority
of PD sufferers requiring treatment (Dimaggio et al., 2013b).
Systematic research on factors associated with premature
treatment interruption has not yet produced conclusive results;
however, it is well known that the drop-out rate in PDs is
particularly high. In an accurate metanalysis conducted by Swift
and Greenberg (2012), the general treatment drop-out rate of
19.7% increased to 25.6% in the case of PDs. Furthermore,
McMurran et al. (2010) discovered that the median drop-
out rate in PD patients was 37%, while in a recent study by
Gamache et al. (2018) the drop-out rate amounted to 40.8%.
These data suggest that it might be particularly relevant to
study the therapeutic process when treating PDs, since this
would help to identify the main factors underlying personality
pathology that might need to be addressed during treatment.
Studies have generally investigated large sets of several pre-
treatment variables without focusing on specific variables selected
for treatment prognosis prediction (Gamache et al., 2018).
These observations call for a remarkable effort in analyzing the
treatment process and understanding the possible mechanisms of
change during psychotherapy.
Additionally, several authors have agreed that therapeutic
intervention should be centered on aspects of general personality
pathology shared in different PDs; among these, a reduced ability
to understand the minds of others seems to be particularly
relevant (Fonagy, 1991; Semerari et al., 2003, 2007, 2014, 2015;
Bateman and Fonagy, 2004, 2009; Minzenberg et al., 2006;
Dimaggio et al., 2007; Gullestad et al., 2013). Moreover, the
DSM 5 stresses the key role of reflective abilities, since in
Section III and establishes that in order to diagnose a PD, it
is crucial to consider the evaluation of the functioning level
of the individual’s personality through their capacity to (1)
self-reflect, thus promoting a stable sense of self and self-
directivity and (2) understand others’ minds in order to establish
and maintain empathetic and good relationships (American
Psychiatric Association [APA], 2013).
The ability of understanding mental states has different
denominations, but in the field of PDs it is often termed
“mentalization” (Bateman and Fonagy, 2004; Bouchard et al.,
2008; Choi-Kain and Gunderson, 2008) or “metacognition”
(Semerari et al., 2003, 2007; Dimaggio and Lysaker, 2010;
Carcione et al., 2011). These two terms have been used in
numerous studies as similar concepts, and there is a broad
consensus indicating that they refer to almost the same
psychological function (Bo et al., 2014; Semerari et al., 2014;
Fonagy and Bateman, 2016).
In this paper, we use the term metacognition to refer to a
set of abilities that are crucial to: (1) identify mental states
and ascribe them to oneself and others on the basis of facial
expressions, somatic states, behaviors, and actions; (2) reflect
and reason on mental states; (3) use information about mental
states to make decisions, solve problems or for psychological
and interpersonal conflicts and to cope with subjective suffering
(Carcione et al., 2010, unpublished).
Only a limited number of studies have investigated the
role of different metacognition abilities in the process of
change during psychotherapy (Levy et al., 2006; Vermote et al.,
2010; Maillard et al., 2017). Some studies have provided data
about the role of mentalization as a moderator of the clinical
outcomes of psychotherapeutic treatment for PDs (Gullestad
et al., 2013). Other studies have investigated the predictive
role of a series of constructs related to metacognition, such
as psychological mindedness (PM; Appelbaum, 1973; Conte
et al., 1990; McCallum et al., 2003; Ogrodniczuk et al., 2011),
alexithymia (Nemiah and Sifneos, 1970), especially in creating
major difficulties in identifying the aim of treatment, (Leweke
et al., 2009; Ogrodniczuk et al., 2010; Nicolò et al., 2011) and
affect-consciousness (AC – Monsen and Monsen, 1999), whose
high pre-treatment levels predict improvements in Cluster C
pathology (Gude et al., 2001).
Within this framework, in this study we assumed that
poor metacognition corresponded to a core element of the
general pathology of personality, the functioning of which
impacts a series of clinical variables (and treatment). Therefore,
we expected that improvements in metacognition would be
associated with improvements in personality pathology.
We explored changes in metacognition and in a series of
clinical variables (i.e., personality dysfunction, symptom distress,
and interpersonal and psychosocial functioning) in a sample of
patients treated for 1 year with a treatment specifically structured
to improve metacognition (i.e., the Metacognitive Interpersonal
Therapy, MIT; Semerari, 1999; Dimaggio et al., 2007, 2011; Fiore
et al., 2008; Dimaggio et al., 2015; Carcione et al., 2016).
To comprehensively evaluate the changes of all the considered
variables, we firstly compared the mean scores at the beginning
of the treatment (T0) and after 1 year (T1). We expected that the
mean scores of personality severity (the number of dysfunctional
traits), symptom distress and interpersonal problems would
decrease, while global functioning and metacognition would
increase after 1 year of treatment. Secondly, we compared the
associations between metacognition and the clinical variables
considered at the beginning of the study and after 1 year
of treatment. If low metacognition is a variable that could
be conceived of as a core aspect across different PDs, then
an improvement in metacognition should predict a reduction
in personality pathology. Specifically, considering that poor
metacognition is related to the severity of personality pathology
measured through the number of PD criteria (according to the
DSM IV-TR; Dimaggio et al., 2013a; Semerari et al., 2014), we
hypothesized that improvements in metacognition are associated
with improvements in personality pathology (i.e., a reduction in
the number of dysfunctional traits). Furthermore, considering
that an understanding of mental states is a requirement to
regulate and master those same states (Carcione et al., 2011),
we also hypothesized that an increase in metacognition is
associated with a reduction in symptom distress among patients
with PDs. Since it is also assumed that understanding the
mental states of oneself and others is fundamental to the
regulation of interpersonal relationships and helps individuals
to overcome interpersonal problems (Dimaggio et al., 2007),
our third hypothesis was that an increase in metacognition
would be associated with a decrease in interpersonal problems.
Additionally, we expected that improvements in metacognition
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were associated with improvements in global psychosocial
functioning. We tested the hypotheses of an association between
changes in metacognition and changes in all of the above
considered clinical variables after 1 year of treatment through the
use of a structural equation model with latent variables.
MATERIALS AND METHODS
Participants
The sample consisted of 193 individuals who completed a 1-
year treatment schedule in an Italian outpatient clinic between
2011 and 2017. The mean age of the sample was 33.37 years
(SD = 9.54), ranging from 18 to 65. 59 participants (44.7%) were
male and 73 (55.3%) were female. All participants met DSM-IV-
TR (American Psychiatric Association [APA], 2000) diagnostic
criteria for PD; DSM-IV Axis I diagnoses were assessed using the
Structured Clinical Interview for the DSM-IV, Axis I Disorders
(SCID-I; First et al., 1996). The inclusion criteria embraced
patients with at least one PD (including those with histories of
suicidal attempts or self-harm). On the other hand, the exclusion
criteria were substance dependence, psychotic disorders, bipolar I
disorder, delirium, dementia, mental retardation, severe medical
conditions which precluded psychiatric medications, and medical
conditions requiring hospitalization. Individuals who were
enrolled in the study provided written informed consent.
Table 1 illustrates the demographic and diagnostic
characteristics of the study sample and the percentage of
PD diagnoses.
Measures
The Structured Clinical Interview for DSM-IV (SCID-II; First
et al., 1997) was used to obtain diagnostic Axis-II profiles on
the basis of the criteria of the DSM-IV (American Psychiatric
Association [APA], 2000), which yielded 11 different categories
of PD diagnoses. In this study, satisfactory inter-rater reliability
was found in the application of the SCID-II. 20 SCID-II were
rated twice; the internal consistency of the PDs traits ranged
from 0.71 to 0.89 for the majority of the PD diagnoses; only four
PDs (obsessive-compulsive, dependent, schizotypal, and passive-
aggressive) achieved alphas above 0.60. The inter-rater reliability
was adequate for both trait scores (a two-way mixed absolute
TABLE 1 | Sample description.
N Gender Age M(SD)
193 83 M (43%) 32.9 (10.1)
110 F (57%)
Percentage of Diagnosis for PDs
AV DEP OBS PA DE PAR ST HIS NAR BDL AS
7.3 10.4 23.8 10.4 10.4 5.2 0.5 2.6 7.8 14.4 1.6
M, Male; F, Female; AV, Avoidant PD; DEP, Dependent PD; OBS, Obsessive
PD; PA, Passive-Aggressive PD; DE, Depressive PD; PAR, Paranoid PD; ST,
Schizotypal PD; HIS, Histrionic PD; NAR, Narcissistic PD; BDL, Borderline PD; AS,
Antisocial PD.
agreement model for the Intraclass Correlation Coefficients
(ICC) ranged from 0.87 to 0.99, mean = 0.94) and categorical
diagnoses (average κ = 0.89).
The Symptom Checklist-90-R (SCL-90-R; Derogatis, 1977;
α = 0.96) is a 90-item self-report inventory designed to reflect
the psychological symptom patterns of psychiatric and medical
patients. It is a measure of the current (state) psychological
symptom status of a patient. The SCL-90-R measures nine
primary symptom dimensions and generates an estimate of global
psychopathology, the Global Severity Index (GSI), which has
been adopted in the current study as a measure of symptoms.
The Inventory of Interpersonal Problems-47 (IIP-47; Italian
version Ubbiali et al., 2011; α = 0.93) is a 47-item self-report
scale which assesses interpersonal problems, and consists of five
subscales: Interpersonal Sensitivity, Interpersonal Ambivalence,
Aggression, Need for Social Approval, and Lack of Sociability.
The Global Assessment of Functioning (GAF; American
Psychiatric Association [APA], 2000) is a valid measure of social
functioning and is currently placed on the fifth axis of the
DSM-IV-TR. It has shown reasonable psychometric properties
(inter-rater reliability of approximately 0.80; Dworkin et al.,
1990). For this study, the inter-rater agreement was good
(ICC, r = 0.80, p< 0.001).
The Metacognition Assessment Interview (MAI). The MAI
(Semerari et al., 2012; Pellecchia et al., 2015) is a semi-
structured clinical interview designed to elicit and evaluate
the metacognitive abilities of the participant during a brief
narrative of a psychologically significant experience or event.
During the interview, the participant is requested to describe the
most troubling interpersonal experience they had experienced
in the previous 6 months, a time frame selected in order to
facilitate recall and to permit test-retest, avoiding recall biases,
in the evaluation of changes during psychotherapy. The reported
experience must be autobiographical, personal and involve
another person, so that the individual’s ability to understand the
mental state of others can be evaluated. Once the description of
the episode is completed, the interviewer asks a list of questions,
divided into four modules, to elicit and evaluate the 16 basic
facets constituting metacognitive sub-functions (four facets are
allocated to each sub-function). The interviewer assigns each of
the 16 basic facets a score ranging from 1 to 5 using a Likert
scale. The metacognitive functions assessed by the MAI are:
Monitoring (MON), Integration (INT), Differentiation (DIF),
Decentration (DEC), and Global score. MON is the ability to
identify and label the components of our mental states in terms
of emotions, thoughts, motivations and desires. People who can
effectively monitor find it easy to give appropriate answers to
questions such as “What do you think?” and “How do you feel?”.
Impairments of this function compromise both the individual’s
ability to describe his/her internal state and their ability to explain
the reasons and motivations underlying his/her behavior. INT
refers to the more general capacity of individuals to reflect
upon different mental states and identify internal contradictions,
conflicts and patterns. This metacognitive function allows us to
adaptively organize mental content in terms of significance and
subjective priority and thus to maintain behavioral coherence.
An INT disorder causes mental processes and behaviors to be
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contradictory and unstable. DIF indicates the individual’s ability
to recognize the representational nature of their mental states,
distinguishing clearly between the internal psychological content
and external reality. In the presence of impaired differentiation,
imagination takes on the properties of the real world. In this
perspective, if the patient is unable to recognize the subjectivity
of his/her mental representations, he/she is also unable to
maintain a critical distance from his/her own representations.
DEC refers to the ability to assume other people’s perspectives
and to make plausible hypotheses about their mental states.
Specifically, it means being able to reflect on others’ intentions,
thoughts and desires, independently of one’s own personal
point of view.
The MAI was tested in two preliminary studies. In the first
study, factor analysis was used to investigate 175 non-clinical
subjects and revealed the presence of two higher order domains,
which can be described, respectively, as the awareness of one’s
own mental state and the awareness of others’ mental states
(Semerari et al., 2012). In the second study, conducted with
the same sample as this study, factor analysis indicated four
factors, consistent with the structure of the MAI sub-functions,
but which also confirmed the higher “two factor” structures
identified in the first study (Pellecchia et al., 2015). Additionally,
this study demonstrated a significant association between the
MAI and alexithymia measured with Toronto Alexithymia Scale
(TAS-20) (Bagby et al., 1994). In particular, MON scores and
MAI global scores were associated with all TAS-20 dimensions
and total scores (with correlation coefficients ranging from 0.24
to 0.39, p < 0.01). Moreover, MAI sub-functions and global
scores resulted in an association with the global evaluation
of interpersonal problems measured with the IIP-47 (Pilkonis
et al., 1996), with a correlation coefficient ranging from 0.19
to 0.27 (p< 0.01).
In the present study, the MAI was administered and scored
by three senior interviewers blind to the clinical diagnosis of the
participants. A preliminary inter-rater reliability evaluation was
carried out on 20 interviews. The ICC was used to estimate the
correlation for every single function rated by different judges.
A two-way mixed absolute agreement model was applied to
conduct the ICC for each dimension of the MAI. The ICC for the
MAI’s functions ranged from 0.55 to 0.72 for MON; from 0.50
to 0.67 for INT; from 0.49 to 78 for DIF; and from 0.45 to 0.61
for DEC; all analyses were significant (p < 0.001) and provided
good inter-rater reliability. The internal consistency of the MAI
dimensions was estimated with Cronbach’s alpha, which ranged
from 0.85 to 0.89.
The Treatment: Metacognitive
Interpersonal Therapy (MIT)
The Metacognitive Interpersonal Therapy (MIT is an integrated
approach, developed by the Third Center of Cognitive
Psychotherapy in Rome, to treat PDs (Carcione et al., 2016).
It aims to improve metacognitive abilities and to master
problematic mental states. This treatment model derives from
a) the analysis of clinical and research literature on PDs and (2)
intensive research investigating the therapeutic process starting
from a descriptive model of psychopathological functioning
(Dimaggio et al., 2007, 2015; Semerari et al., 2014).
Metacognitive interpersonal therapy was developed within the
framework of CBT, but it integrates the different procedures
and techniques developed, even from a non-CBT approach
(i.e., Mentalization Based Treatment-MBT, Dialectical Behavior
Therapy-DBT), for the treatment of PDs. In particular, MIT
shares with MBT the constant attention and focus on the patient’s
reflective abilities and their efforts to increase these abilities as its
principal aim.
Metacognitive interpersonal therapy can be
schematically divided into five phases focused on different
metacognitive functions:
(1) In the first phase, the principal aim is to develop the
patient’s ability to monitor problematic states. The therapist
attempts to make the patient aware of (a) the primary
emotion, which is the basis of these states and (b) the
intentions, motivations and goals underlying the most
dangerous behaviors for the patient and which prevent a
good therapeutic alliance from developing.
(2) The aim of the second phase is to develop an integrated
view (i.e., the INT ability) of the current trends in the
patient’s mental state. The therapist tries to: (a) focus on
the transition of the states; (b) highlight the contradictions
and conflicts and (c) reconstruct the modifications of the
problematic states in conjunction with the patient. The
awareness of the dynamics of the states is the basis for the
greater tolerance of suffering which itself is increased using
mindfulness and experiential techniques.
(3) The third phase is focused on the patient’s ability to
consider the representational nature of thoughts. The
therapist uses CBT techniques to promote the patient’s
differentiation abilities, helping them to distinguish
between representation and reality and to consider the
subjectivity of one’s own point of view. In these two phases,
the mastery of problematic states is achieved through
behavioral modifications using cognitive behavioral and
DBT techniques.
(4) In the fourth phase, the aim is to increase the awareness of
dysfunctional interpersonal cycles (according to Safran and
Segal, 1990; Safran and Muran, 2000). The therapist has to
(a) focus on the self and interpersonal schemas (self/other
representations) and (b) promote differentiation and
decentration abilities using cognitive therapy procedures.
(5) The aim of the fifth phase is to develop a sense of
self-agency. The therapist helps the patient to build
autobiographical continuity in which the troubles and how
he/she coped with them emerge in a coherent narrative.
The therapist, throughout the duration of the psychotherapy,
must, at the right moment, debate with the patient the behavioral
and problem solving (i.e., mastery) strategies spontaneously
adopted, encouraging those which are more adaptive to cope with
distress and interpersonal problems.
In addition to individual therapy, MIT can also provide
group intervention aimed at improving metacognition
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using psychoeducation and role-playing techniques, with
particular attention paid to the impact of metacognition on
relational aspects.
Procedure
All measures were administered at baseline (pre-treatment) and
after 1 year of treatment. SCL-90-R and IIP-47 were self-reported
by the patients; GAF was reported by a clinician, SCID-II
interviews and MAI at T0 and T1 were administered by a clinical
team of psychologists and psychiatrists from the Third Center of
Cognitive Psychotherapy in Rome, Italy. Each patient was rated
by the same clinician at both T0 and T1.
The therapists were psychiatrists and psychologists, all trained
in CBT, with an expertise in PDs and an experience ranging
from 5 to 35 years. The sample comprises outpatients who
sought the services of a private clinical center (Third Center
of Cognitive Psychotherapy). Patients followed a thorough
assessment procedure: first, patients are interviewed by a senior
psychiatrist and psychotherapist (at least 20 years of experience);
thus, several diagnostic and clinical tests are administered and
a diagnosis is established; then, in a team meeting, the patient
is assigned to a psychotherapist, taking into consideration
the peculiarities of the specific case and the expertise of
the psychotherapist in treating similar cases. The center’s
organizational procedure includes weekly team meetings for
the discussion of the most complex cases, and to monitor the
ongoing therapies.
The study was extensively explained to each participant, who
signed a written consent form before entering into the study.
Following the informed consent, all participants completed each
of the self-report measures, and were then assessed during
interviews. After the first evaluation (T0), participants were
assigned to a therapist and attended the sessions every week for
1 year before being evaluated again (T1).
Statistical Analyses
To test our hypotheses, the statistical analyses were divided into
two phases. We firstly computed the number of SCID-II criteria
met by each individual participating in the study; the resulting
score was considered to be a global measure of the severity
of personality pathology. An analysis of internal consistency
supported the view that a general severity composite may be
represented this way (at T0 α = 0.74; at T1 α = 0.88; Hopwood
et al., 2011; Semerari et al., 2014).
During the first phase, a series of repeated ANOVA measures
were computed in order to evaluate changes on all measures
between early and late treatment. All results were evaluated
against Holm’s sequential Bonferroni correction (Holm, 1979),
and adjustments to alpha values were made to protect against
inflated family-wise error rates.
Secondly, to investigate the role of metacognition in predicting
changes in the severity of clinical variables we specified a
structural equation model with latent variables, conceptually
summarized in Figure 1. We modeled a latent criterion
(or dependent variable), here termed “Clinical Variable,”, that
summarized the observed variables relating to an array of clinical
indicators (SCL90R-GSI, IIP-47, SCID II criteria, and GAF
Differences in MAI
Clinical Variable 
at T0
Clinical Variable 
at T1
FIGURE 1 | Conceptual diagram of the model.
scores) at T1 (i.e., after 1 year of treatment). The latent predictor
of improvements in metacognition was then linked to Clinical
Variable at T1. To control for spurious effects, a latent variable
Clinical Variable at T0 (using the same indicators as in T1) was
also specified and linked with Clinical Variable at T1. Thus, any
effect for metacognition on the T1 Clinical Variable cannot be
traced back to spurious associations through Clinical Variable at
T0. We expected that, over and above the association between
Clinical Variable across the T0 and T1 time-lag, improvements in
metacognition would be negatively associated (i.e., decrease) with
the level of Clinical Variable at T1. A statistical analysis of the data
was performed using SPSS 20.0 and LISREL 8.8.
RESULTS
Changes Between Early and Late
Treatment on Clinical and Functioning
Measures
Table 2 presents the means and standard deviations for both
outcome and predictor variables at T0 (the beginning of
the treatment) and T1 (1 year later). Additionally, Table 2
summarizes the results for the repeated measures ANOVA for
each variable. At T0, data showed generally high levels of
severity and distress, and low scores of general functioning.
At T1, the means showed significant changes compared with
T0, indicating a general improvement in personality severity,
symptom distress and levels of psychosocial and interpersonal
functioning. Turning to levels of metacognition, a significant
improvement was observed from T0 to T1. Such an improvement
was detectable in both the MAI Global Score and the four MAI
facets (Table 2).
Changes in Metacognition and Clinical
Variables
We tested the structural equation model with the latent variables
depicted in Figure 2 (the obtained parameter estimates are
summarized in the figure). A latent factor indexed by the
observed scores at T1 (i.e., after 1 year of treatment) in the PD
severity scores (the number of PD criteria met during SCID
II) and also in the SCL90R-GSI scores, interpersonal problems
(IIP-47) and GAF scores played the role of the dependent (or
endogenous) variable. This Clinical Variable at T1 latent factor
was predicted in the model by two independent latent factors.
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TABLE 2 | Outcome and predictor measure changes between early and late treatment (Repeated-measures ANOVA results of included variables).
Measures Early Mean (SD) Late Mean (SD) Mean Difference Fs Partial Eta Squared
PD Severity 16.30 (6.59) 9.34 (6.39) 6.96 F(1,190) = 291.49∗∗ 0.61
GSI 1.38 (0.59) 0.83 (0.55) 0.55 F(1,182) = 184.74∗∗ 0.50
IIP-47 1.74 (0.65) 1.35 (0.64) 0.40 F(1,184) = 80.57∗∗ 0.31
GAF 65.55 (10.15) 75.36 (11.41) −9.81 F(1,149) = 138.50∗∗ 0.48
MAI
Monitoring 12.37 (2.71) 14.51 (2.12) −2.14 F(1,182) = 122.86∗∗ 0.41
Integration 11.13 (2.52) 13.21 (2.08) −2.08 F(1,182) = 121.20∗∗ 0.40
Differentiation 10.92 (2.74) 13.39 (1.93) −2.47 F(1,182) = 146.43∗∗ 0.45
Decentration 10.91 (2.73) 12.81 (2.38) −1.90 F(1,182) = 103.23∗∗ 0.36
Total score 45.33 (9.26) 53.92 (7.19) −8.59 F(1,182) = 182.10∗∗ 0.50
PD Severity, number of criteria met at the SCID-II (N = 191); GSI, SCL90-R Global Severity Index (N = 183); IIP-47, Inventory of Interpersonal Problems (N = 185); GAF,
Global Assessment of Functioning (N = 150); MAI, Metacognition Assessment Interview (N = 183). ∗∗p < 0.001.
Clinical Variable at T0
Differences in MAI
Clinical Variable at T1
GSI T0
PD SEV 
T0
DIFF
INT
DEC
MON
GSI T1
GAF T1
IIP T1
PD SEV 
T1
.62
-.68
.36
.77
.76
.85
IIP T0
GAF 
T0
.66
.66
-.17
.53
.67
.78
-.38
.82
FIGURE 2 | Structural equation model: Parameter estimates. Note: All parameters are significant. GSI, SCL90-R-Global Severity Index; IIP, Inventory of Interpersonal
Problems; GAF, Global Assessment of Functioning; PD SEV, number of criteria met at the SCID-II; MON, Monitoring; DIFF, Differentiation; INT, Integration; DEC,
Decentration; MAI, Metacognition Assessment Interview.
A first predictor, which mainly played a control role, was a latent
factor Clinical Variable at T0, indexed by the PD severity scores,
SCL90R-GSI, IIP-47 and GAF scores measured at T0 (at the
beginning of the treatment). The second latent predictor was a
“Change in Metacognition” factor, indexed by four difference-
score indicators (T1-T0), one for each metacognition facet of
the MAI. Utilizing the latent variables enables the study to
more accurately predict the regression coefficients (because the
measurement error is explicitly modeled and does not attenuate
regression parameter estimates). This confirmative model also
allows the testing of the global fit in terms of the ability of the
model parameters to reproduce the observed data (Bollen, 1989).
A Maximum Likelihood estimation was used to obtain the
parameter estimates and standard errors. The ability of the
model to reproduce the data is directly evaluated by a chi-square
statistic; however, the chi-square statistic is excessively restrictive
for large samples (Bollen, 1989), and therefore we would also
evaluate the model fit by assessing the root mean square error
of approximation (RMSEA), the comparative fit index (CFI), the
non-normed fit index (NNFI), and the standardized root mean
square residual (SRMR), as suggested by Hu and Bentler (1999).
These latter indices are generally unaffected by sample size and
provide a more comprehensive view of the model fit.
The model fitted the data satisfactorily. Although the chi-
square statistic was significant [χ2(47, N = 218) = 84.11,
p = 0.0007], the other fit indexes pointed to a reasonable
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fit: RMSEA = 0.060 [90% C.I. 0.039; 0.081]; CFI = 0.97;
NNFI = 0.96; SRMR = 0.059. The RMSEA value was statistically
undistinguishable from the so-called “close fit” hypothesis
(RMSEA = 0.05), indicating negligible deviations in the
reproduced data. CFI and NFFI were above the threshold of
0.95 generally associated with good fit, and the SRMR was below
0.08 (Hu and Bentler, 1999). The model appeared therefore
fairly satisfactory.
Figure 2 summarizes the main parameter estimates. The
measurement models (factor loadings) demonstrated satisfactory
values, with significant loadings with the expected sign. Turning
to the structural parameter estimates linking the latent variables,
as should be expected, Clinical Variable at T0 were significantly
and strongly linked with Clinical Variable at T1. Interestingly,
once the cross-lag association between Clinical Variable across T0
and T1 was controlled for, increases in the metacognition scores
were associated with decreases in Clinical Variable at T1.
DISCUSSION
Our study entered into the research field surrounding the existing
relations between metacognition and its role in the outcome of
treatment for PDs. Our purpose was to measure the specific
functions of metacognition, their changes during treatment and
their role as a predictor of personality severity changes and other
outcome measures.
This study does not aim to assess the effectiveness of a specific
treatment. Nevertheless, we believe that, given the lack of a
broad range of sensitive measures of cognitive and affective
dysfunctions found in PDs (Luyten et al., 2012; Chiesa and
Fonagy, 2014), our study could add empirical evidence about
the role of specific variables that are important to reduce
therapeutic failures.
We firstly evaluated the mean differences in personality
severity, symptom distress, interpersonal problems, global
functioning, and metacognition both at the beginning of a
treatment based on metacognition (MIT) and after 1 year of
treatment. The results showed a general improvement in all the
variables considered.
In the second hypothesis, we supposed that those
improvements could be predicted by improved metacognition
functioning developed by the patient during 1 year of
MIT treatment. The results appeared consistent with
these expectations.
These results can be discussed from two points of view:
what they indicate with respect to the pathology of the
individual’s personality, and what they indicate with respect to
the psychotherapeutic process of PD patients.
From the point of view of personality pathology, if the
initial general hypothesis that low metacognition is one of the
general factors underlying this pathology is true, a metacognitive
improvement would consequently be associated with a general
improvement in the clinical variables associated with the
disorder. Our data, through a structural equation model with
latent variables, lent support to this argument, constituting
indirect support to the central role played by low metacognition
in PDs. The reported results are consistent with previous
findings (Semerari et al., 2003, 2007, 2014, 2015; Bateman
and Fonagy, 2004; Minzenberg et al., 2006; Dimaggio et al.,
2007; Gullestad et al., 2013) that considered difficulties in
understanding one’s own and others’ minds as core aspects
of PDs. For example, Herpertz and Bertsch (2014) considered
impairments in social cognition (i.e., facial emotion recognition,
cognitive and emotional empathy, and theory of mind) to be a
core concept that characterizes PDs. Other authors (Antonsen
et al., 2016; Hayden et al., 2018) found an association between
Reflective Function (RF) and the intensity of symptom distress
and psychosocial impairment. Semerari et al. (2014) supported
evidence that (1) metacognition is specifically impaired in
PDs if compared to a clinical sample of non-PD patients, (2)
the dysfunction is significantly correlated to the severity of
personality pathology (measured as the number of criteria met
in the SCID II) and (3) difficulties in metacognition are specific
to different PDs (Semerari et al., 2007), for example in BPD
(Semerari et al., 2005, 2015) and in Avoidant PD (AvPD) patients
Pellecchia et al. (2018).
Furthermore, Pellecchia et al. (2018) compared patients with
Social Phobia (SP), with AvPD, with both AvPD and SP and
with other PDs without SP or AvPD criteria on metacognitive
abilities, interpersonal functioning and global symptomatic
distress. They found that patients with AvPD and AvPD+SP
groups demonstrate poorer metacognition compared with SP
patients; moreover, no differences were found in metacognition
capacity between the groups with an AvPD diagnosis (AvPD+SP
and AvPD) and the PD group without an AvPD diagnosis, which
is consistent with the notion that poor metacognitive functioning
is an element that differentiates personality pathology from
anxiety disorders.
From the point of view of the impact on psychotherapeutic
treatment, our data support the hypothesis that an increase
in metacognitive abilities is a factor of change in personality
pathology. Similarly, Chiesa and Fonagy (2014) found the
mediator role of mentalization between early adverse experiences
and PD diagnoses and between adversity and psychiatric
distress. Our results are consistent with Gullestad et al. (2013),
which provided data about the role of mentalization in
psychotherapeutic treatment for PDs, and with other studies that
have investigated the predictive value of related concepts, like
psychological mindedness (PM) (Appelbaum, 1973), alexithymia
(Nemiah and Sifneos, 1970) and affect-consciousness (Monsen
and Monsen, 1999). Higher pre-treatment levels of PM have
been found to predict favorable outcomes (Conte et al., 1990;
McCallum et al., 2003; Ogrodniczuk et al., 2011). Additionally,
convergent evidence shows that alexithymia impacts treatment,
for example by creating major difficulties in identifying treatment
aims or in generating negative reactions in the therapists (Leweke
et al., 2009; Ogrodniczuk et al., 2010; Nicolò et al., 2011).
Finally, in a study that examined the relationship between Affect
Consciousness (AC) and cluster C personality pathology, a high
pre-treatment level of AC predicted a reduction in avoidant
personality pathology, but not in dependent or obsessive-
compulsive PD-traits. One exception is the data of Gude et al.
(2001), where an increase in AC during therapy was not
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associated with improvements in personality pathology. This
difference could be due to the fact that AC covers only some
aspects of reflective abilities, as the ability to perceive and
organize specific affects, while metacognition includes several
other abilities in understanding one’s own and others’ minds
(including not only emotional but also cognitive awareness). This
difference could mean that metacognition, as measured through
the MAI, clinically captures more relevant functioning.
Together, the data encourage the investigation of aspects of
functioning underlying the various PDs and the refinement of
the intervention focusing on these dimensions, in line with the
suggestion of Bateman and Fonagy (2009).
Limitations
The present study has a number of limitations that should
be acknowledged. Firstly, data are mostly based on self-report
measures (i.e., symptom distress and interpersonal problems).
However, it should also be emphasized that the main variable
of the present study (i.e., metacognition) was measured through
a semi-structured interview, assuaging concerns of inflated
associations due to common method biases. Moreover, other
variables of interest, such as alexithymia levels, should be added
in future studies concerning metacognition.
To obtain a fairly-sized sample, we did not distinguish among
different PDs. Further studies could be extended in larger groups
representing specific diagnoses. Nonetheless, our study was
mainly concerned with the severity of personality functioning
and distress, therefore our sample and methods appeared to be
consistent with our research perspective. Moreover, we did not
include a follow-up measurement, so we could not verify whether
the improvement we depicted would change or remain constant
after 1 year of treatment.
Finally, the design of our study was not aimed at testing the
effectiveness of MIT treatment on PDs or to measure the drop-
out rate. What our study does provide is corroborating evidence
that improvements in metacognitive abilities go hand-in-hand
with improvements in the severity of personality pathology
and its associated symptoms. Future research should consist of
clinical trials in order to determine whether a possible causal
relationship exists between improvements in metacognition and
a series of outcome variables, and to test if a psychotherapy
for PDs focused on metacognition would actually reduce the
drop-out rate compared with other psychotherapies.
CONCLUSION
Our data supported the hypothesis that changes in metacognitive
functioning would explain a significant portion of personality
pathology, together with an improvement in symptoms and
interpersonal and social functioning after 1 year of treatment.
The reduction in distress levels can be explained by the fact that
metacognition abilities might increase individuals’ ability to cope
with mental states as a source of subjective suffering, showing
that the metacognition construct is able to capture clinically
relevant phenomena.
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